Molecular Psychiatry

(The H4-Index of Molecular Psychiatry is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies940
The Amyloid-β Pathway in Alzheimer’s Disease478
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States390
Diet and depression: exploring the biological mechanisms of action266
The serotonin theory of depression: a systematic umbrella review of the evidence244
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies192
The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic186
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative178
Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients171
Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a meta-analysis and systematic review169
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study169
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia161
Autism spectrum heterogeneity: fact or artifact?148
The blood-brain barrier in aging and neurodegeneration145
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability134
The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression131
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders128
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies128
Polysubstance use in the U.S. opioid crisis124
Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group123
Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research123
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor115
Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications113
Treatment resistance in psychiatry: state of the art and new directions112
Brain oxytocin: how puzzle stones from animal studies translate into psychiatry108
A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action106
Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak103
The gut microbiome modulates gut–brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression101
Oligodendrocyte lineage cells and depression101
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology101
Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts99
All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders96
Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation96
The neuroendocrinology of stress: the stress-related continuum of chronic disease development95
Recognizing the importance of childhood maltreatment as a critical factor in psychiatric diagnoses, treatment, research, prevention, and education95
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications92
Updated review of research on the gut microbiota and their relation to depression in animals and human beings86
Molecular pathways of major depressive disorder converge on the synapse85
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine83
Toward a neurocircuit-based taxonomy to guide treatment of obsessive–compulsive disorder82
Disrupted intrinsic functional brain topology in patients with major depressive disorder81
Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation76
Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions76
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action74
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials74
Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis73
Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids72
Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort72
Machine learning for genetic prediction of psychiatric disorders: a systematic review71
Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials71
Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders70
Mechanisms of action of fluvoxamine for COVID-19: a historical review69
Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways68
Genomic analysis of diet composition finds novel loci and associations with health and lifestyle68
Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes68
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study68
Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis67
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis66
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials66
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment65
The acid sphingomyelinase/ceramide system in COVID-1965
Loss of function of the mitochondrial peptidase PITRM1 induces proteotoxic stress and Alzheimer’s disease-like pathology in human cerebral organoids64
Putting the “mental” back in “mental disorders”: a perspective from research on fear and anxiety64
Neuronal activity increases translocator protein (TSPO) levels64
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis64
Appropriate exercise level attenuates gut dysbiosis and valeric acid increase to improve neuroplasticity and cognitive function after surgery in mice64